Testimony Before the FDA’s Vaccines and Related Biological Products Advisory Committee Regarding the EUA of the Janssen COVID-19 Vaccine
In testimony before a meeting of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee, Public Citizen agreed with the need for an Emergency Use Authorization (EUA) for the Janssen COVID-19 vaccine, but raised questions about whether and when placebo-group subjects in the clinical trials of the Pfizer, Moderna, and Janssen COVID-19 vaccines would be notified of their status and offered a COVID-19 vaccine.
See Public Citizen’s other work on the coronavirus pandemic.